Dr. Lal PathLabs has informed that it attached a copy of Company's Q3 & 9M FY24 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2023, as approved by the Board of Directors in their meeting held on February 01, 2024.
The above information is a part of company’s filings submitted to BSE.